Blue Owl Capital Holdings LP Pliant Therapeutics, Inc. Transaction History
Blue Owl Capital Holdings LP
- $234 Million
- Q4 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 2,769,199 shares of PLRX stock, worth $9.11 Million. This represents 15.59% of its overall portfolio holdings.
Number of Shares
2,769,199
Previous 3,004,199
7.82%
Holding current value
$9.11 Million
Previous $33.7 Million
8.29%
% of portfolio
15.59%
Previous 11.1%
Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
65.8MCall Options Held
230KPut Options Held
746K-
Deep Track Capital, LP Greenwich, CT5.97MShares$19.6 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$16.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$15.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$10.6 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$10.5 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $160M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...